Member Info for alkin

https://twitter.com/Whiters63/status/1438765910941110274

SNG needs more of a push behind it. Big pharma's constantly push snippets and spend lots of money promoting themselves and any drugs no matter how good they are...
Hard to compete but the results will speak for themselves...

Government experts are recommending against hydrogen in homes and say we should go electric

Hi, I dumped 25k earlier but still holding over 70k shares...

Sensetalka, what math have you done to be very happy with your investment?
I agree PHE's technology is where we need to be but until such time the orders start flying in, any investment is speculative at best.

Anyone know why volumes have dropped off today?

Apple and Microsoft - good company, love it!
It PHE were an Apple or Microsoft we would all be happy, alas when comparing PHE to its peers, it pays to remember that if they had 10 times less shares, they would be worth 10 times more :-)

Hi 1LEO, you probably forgot the most important item, there are 3.9bn PHE shares, this is 10+ times more than most companies.
If you factor that in, PHE shares would be c. 50p. At 50p there would be a lot more volatility...

Lots of automated trades today

Looking good, although suspect some will dump shares as 8% hike in one day is a good profit. Second week we have seen a spike, fingers crossed this one doesn't fizzle out early next week.

Quick question, will you ever be able to use the channel tunnel with a hydrogen car?

swazers - 10p will happen if some really good news and real sales. The amount of shares does mean a significant uplift is needed, short term I suspect we will see 4p first.

You obviously haven't been following PHE for long....
PHE goes up and down like a yoyo, I normally go back in around 3p.
Welcome to the world of AIM shares

Competition isn't the issue for PHE, it is getting deals done and a worthy CEO

We know SNG001 works, keep the faith.
The SP is based on profit taking, the increase was due to new positions...

So, Synairgen has c. 200m shares in circulation and working on assumptive £582m turnover profits would be approx £500m that is equivalent of £2.50 per share. If you take a fv based on a conservative 70% increase on an annual basis and work to 5 years out, you should then be at £4.1bn ~ £20 per share.
However, working purely on multiples you would be looking at x15 which would give around £7.5bn ~ £37 per share.
Either way, the future looks good :-)

Anyone who thinks Coronavirus is going anywhere in the next 10 years is overly optimistic. The guardian article would be effectively year 1 income and this should grow exponentially as vaccines continue to fail against variants.
We need to get to the point where we see coronavirus in the same way as the flu, there will continue to be casualties but people can go about their lives as they would with the flu.
£20 was on the conservative side, would suspect they will get snapped up by a large pharma and based on the potential of SNG001, its highly probably there will be a bidding war.

Hiya, I normally wait for 3.x p, nearly always seem to get down to that level after a rise.
Good CEO and proper orders are needed to secure a steady rise which I believe and hope will come as good technology.

The Guardian forecast will make Synairgen worth £20 per share at least! Happy days

Good article showing the lengths Covid19 goes to to block interferon production. I starting investing in SNG back in July once their success became public knowledge and am looking forward to the day when it is available at all hospitals so that we may stop all these unnecessary deaths and get back on with our lives